nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloroquine—GSTA2—Azathioprine—systemic scleroderma	0.501	0.618	CbGbCtD
Chloroquine—CYP2C8—Mometasone—systemic scleroderma	0.081	0.1	CbGbCtD
Chloroquine—ABCB1—Lisinopril—systemic scleroderma	0.037	0.0457	CbGbCtD
Chloroquine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0335	0.0414	CbGbCtD
Chloroquine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0323	0.0398	CbGbCtD
Chloroquine—ABCB1—Captopril—systemic scleroderma	0.0277	0.0342	CbGbCtD
Chloroquine—CYP2D6—Captopril—systemic scleroderma	0.0261	0.0323	CbGbCtD
Chloroquine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0218	0.027	CbGbCtD
Chloroquine—ABCB1—Prednisone—systemic scleroderma	0.0175	0.0216	CbGbCtD
Chloroquine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0131	0.0162	CbGbCtD
Chloroquine—CYP3A4—Prednisone—systemic scleroderma	0.0105	0.0129	CbGbCtD
Chloroquine—ABCB1—Methotrexate—systemic scleroderma	0.00876	0.0108	CbGbCtD
Chloroquine—TNF—Cytokines and Inflammatory Response—CSF1—systemic scleroderma	0.0015	0.0294	CbGpPWpGaD
Chloroquine—TNF—amb2 Integrin signaling—SELP—systemic scleroderma	0.00136	0.0266	CbGpPWpGaD
Chloroquine—TNF—Canonical NF-kappaB pathway—TNFAIP3—systemic scleroderma	0.00132	0.0259	CbGpPWpGaD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—IRF5—systemic scleroderma	0.00123	0.0242	CbGpPWpGaD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL13—systemic scleroderma	0.00117	0.023	CbGpPWpGaD
Chloroquine—TNF—Caspase Cascade in Apoptosis—TOP1—systemic scleroderma	0.00116	0.0227	CbGpPWpGaD
Chloroquine—TNF—IL27-mediated signaling events—STAT4—systemic scleroderma	0.00113	0.0221	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—AIF1—systemic scleroderma	0.0011	0.0215	CbGpPWpGaD
Chloroquine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—SMAD7—systemic scleroderma	0.00109	0.0214	CbGpPWpGaD
Chloroquine—TNF—amb2 Integrin signaling—ITGAM—systemic scleroderma	0.00108	0.0213	CbGpPWpGaD
Chloroquine—TNF—TGF-beta Receptor Signaling—SMAD7—systemic scleroderma	0.00108	0.0211	CbGpPWpGaD
Chloroquine—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CD247—systemic scleroderma	0.00106	0.0208	CbGpPWpGaD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IRF5—systemic scleroderma	0.000962	0.0189	CbGpPWpGaD
Chloroquine—TLR9—Toll-Like Receptors Cascades—ITGAM—systemic scleroderma	0.000909	0.0178	CbGpPWpGaD
Chloroquine—TNF—amb2 Integrin signaling—CTGF—systemic scleroderma	0.000905	0.0178	CbGpPWpGaD
Chloroquine—TNF—Signaling events mediated by HDAC Class I—SMAD7—systemic scleroderma	0.000875	0.0172	CbGpPWpGaD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNFAIP3—systemic scleroderma	0.000861	0.0169	CbGpPWpGaD
Chloroquine—TNF—IL23-mediated signaling events—STAT4—systemic scleroderma	0.00085	0.0167	CbGpPWpGaD
Chloroquine—TNF—TNF receptor signaling pathway —TNFAIP3—systemic scleroderma	0.00076	0.0149	CbGpPWpGaD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL1A—systemic scleroderma	0.000736	0.0144	CbGpPWpGaD
Chloroquine—TNF—Folate Metabolism—CSF1—systemic scleroderma	0.000733	0.0144	CbGpPWpGaD
Chloroquine—Hepatitis—Captopril—systemic scleroderma	0.000693	0.00498	CcSEcCtD
Chloroquine—Convulsion—Pentoxifylline—systemic scleroderma	0.000689	0.00496	CcSEcCtD
Chloroquine—Hallucination—Captopril—systemic scleroderma	0.000689	0.00496	CcSEcCtD
Chloroquine—Pancytopenia—Leflunomide—systemic scleroderma	0.000677	0.00487	CcSEcCtD
Chloroquine—Anxiety—Pentoxifylline—systemic scleroderma	0.000675	0.00485	CcSEcCtD
Chloroquine—Delirium—Prednisone—systemic scleroderma	0.000675	0.00485	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Azathioprine—systemic scleroderma	0.000668	0.0048	CcSEcCtD
Chloroquine—Neutropenia—Leflunomide—systemic scleroderma	0.000667	0.0048	CcSEcCtD
Chloroquine—Visual disturbance—Mycophenolate mofetil—systemic scleroderma	0.000656	0.00471	CcSEcCtD
Chloroquine—Erythema multiforme—Captopril—systemic scleroderma	0.000655	0.00471	CcSEcCtD
Chloroquine—Confusional state—Pentoxifylline—systemic scleroderma	0.000655	0.00471	CcSEcCtD
Chloroquine—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.000649	0.00467	CcSEcCtD
Chloroquine—Pancytopenia—Mycophenolic acid—systemic scleroderma	0.000646	0.00465	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Lisinopril—systemic scleroderma	0.000639	0.00459	CcSEcCtD
Chloroquine—Neutropenia—Mycophenolic acid—systemic scleroderma	0.000636	0.00457	CcSEcCtD
Chloroquine—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.000636	0.00457	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.000631	0.00453	CcSEcCtD
Chloroquine—Agranulocytosis—Azathioprine—systemic scleroderma	0.000628	0.00452	CcSEcCtD
Chloroquine—Angioedema—Mometasone—systemic scleroderma	0.000627	0.00451	CcSEcCtD
Chloroquine—Anorexia—Pentoxifylline—systemic scleroderma	0.000619	0.00445	CcSEcCtD
Chloroquine—Alopecia—Captopril—systemic scleroderma	0.000612	0.0044	CcSEcCtD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—CD247—systemic scleroderma	0.000608	0.0119	CbGpPWpGaD
Chloroquine—Eosinophilia—Lisinopril—systemic scleroderma	0.000607	0.00436	CcSEcCtD
Chloroquine—Hypotension—Pentoxifylline—systemic scleroderma	0.000607	0.00436	CcSEcCtD
Chloroquine—Psychotic disorder—Mycophenolate mofetil—systemic scleroderma	0.000607	0.00436	CcSEcCtD
Chloroquine—Agranulocytosis—Leflunomide—systemic scleroderma	0.000594	0.00427	CcSEcCtD
Chloroquine—Insomnia—Pentoxifylline—systemic scleroderma	0.000587	0.00422	CcSEcCtD
Chloroquine—Pancytopenia—Lisinopril—systemic scleroderma	0.000582	0.00418	CcSEcCtD
Chloroquine—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	0.000577	0.0113	CbGpPWpGaD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic scleroderma	0.000575	0.0113	CbGpPWpGaD
Chloroquine—Neutropenia—Lisinopril—systemic scleroderma	0.000573	0.00412	CcSEcCtD
Chloroquine—TNF—Matrix Metalloproteinases—MMP1—systemic scleroderma	0.000572	0.0112	CbGpPWpGaD
Chloroquine—Erythema multiforme—Azathioprine—systemic scleroderma	0.000572	0.00411	CcSEcCtD
Chloroquine—Hepatitis—Leflunomide—systemic scleroderma	0.000571	0.0041	CcSEcCtD
Chloroquine—Vision blurred—Captopril—systemic scleroderma	0.000568	0.00409	CcSEcCtD
Chloroquine—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.000566	0.00407	CcSEcCtD
Chloroquine—Decreased appetite—Pentoxifylline—systemic scleroderma	0.000565	0.00406	CcSEcCtD
Chloroquine—Anaphylactic shock—Mometasone—systemic scleroderma	0.00056	0.00403	CcSEcCtD
Chloroquine—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.000559	0.00402	CcSEcCtD
Chloroquine—Skin exfoliation—Prednisone—systemic scleroderma	0.000554	0.00398	CcSEcCtD
Chloroquine—Angioedema—Captopril—systemic scleroderma	0.000551	0.00396	CcSEcCtD
Chloroquine—Hepatitis—Mycophenolic acid—systemic scleroderma	0.000545	0.00392	CcSEcCtD
Chloroquine—Hallucination—Mycophenolic acid—systemic scleroderma	0.000542	0.0039	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.000542	0.0039	CcSEcCtD
Chloroquine—Erythema multiforme—Leflunomide—systemic scleroderma	0.00054	0.00388	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—TNFSF13—systemic scleroderma	0.000536	0.0105	CbGpPWpGaD
Chloroquine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.000535	0.00385	CcSEcCtD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—STAT4—systemic scleroderma	0.000535	0.0105	CbGpPWpGaD
Chloroquine—Alopecia—Azathioprine—systemic scleroderma	0.000534	0.00384	CcSEcCtD
Chloroquine—Anorexia—Mometasone—systemic scleroderma	0.000534	0.00384	CcSEcCtD
Chloroquine—Visual impairment—Mycophenolic acid—systemic scleroderma	0.000525	0.00377	CcSEcCtD
Chloroquine—TNF—Apoptosis—IRF5—systemic scleroderma	0.000524	0.0103	CbGpPWpGaD
Chloroquine—TNF—FAS pathway and Stress induction of HSP regulation—IL1A—systemic scleroderma	0.000517	0.0101	CbGpPWpGaD
Chloroquine—Urticaria—Pentoxifylline—systemic scleroderma	0.000516	0.00371	CcSEcCtD
Chloroquine—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000513	0.00369	CcSEcCtD
Chloroquine—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.00051	0.00367	CcSEcCtD
Chloroquine—Agranulocytosis—Lisinopril—systemic scleroderma	0.00051	0.00367	CcSEcCtD
Chloroquine—Tinnitus—Mycophenolic acid—systemic scleroderma	0.000508	0.00365	CcSEcCtD
Chloroquine—Alopecia—Leflunomide—systemic scleroderma	0.000505	0.00363	CcSEcCtD
Chloroquine—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.000502	0.00361	CcSEcCtD
Chloroquine—Confusional state—Captopril—systemic scleroderma	0.000496	0.00357	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—IL13—systemic scleroderma	0.000496	0.00972	CbGpPWpGaD
Chloroquine—Anaphylactic shock—Captopril—systemic scleroderma	0.000492	0.00354	CcSEcCtD
Chloroquine—Hepatitis—Lisinopril—systemic scleroderma	0.000491	0.00353	CcSEcCtD
Chloroquine—Hallucination—Lisinopril—systemic scleroderma	0.000488	0.00351	CcSEcCtD
Chloroquine—Decreased appetite—Mometasone—systemic scleroderma	0.000487	0.0035	CcSEcCtD
Chloroquine—Thrombocytopenia—Captopril—systemic scleroderma	0.000482	0.00346	CcSEcCtD
Chloroquine—Alopecia—Mycophenolic acid—systemic scleroderma	0.000481	0.00346	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—SELP—systemic scleroderma	0.000478	0.00937	CbGpPWpGaD
Chloroquine—Anorexia—Captopril—systemic scleroderma	0.000469	0.00337	CcSEcCtD
Chloroquine—Vision blurred—Leflunomide—systemic scleroderma	0.000468	0.00337	CcSEcCtD
Chloroquine—Asthenia—Pentoxifylline—systemic scleroderma	0.000466	0.00335	CcSEcCtD
Chloroquine—Erythema multiforme—Lisinopril—systemic scleroderma	0.000464	0.00333	CcSEcCtD
Chloroquine—Skin exfoliation—Methotrexate—systemic scleroderma	0.000463	0.00333	CcSEcCtD
Chloroquine—Hypotension—Captopril—systemic scleroderma	0.00046	0.00331	CcSEcCtD
Chloroquine—Pruritus—Pentoxifylline—systemic scleroderma	0.000459	0.0033	CcSEcCtD
Chloroquine—Tinnitus—Lisinopril—systemic scleroderma	0.000457	0.00329	CcSEcCtD
Chloroquine—Aplastic anaemia—Methotrexate—systemic scleroderma	0.000455	0.00327	CcSEcCtD
Chloroquine—Angioedema—Leflunomide—systemic scleroderma	0.000454	0.00326	CcSEcCtD
Chloroquine—TNF—Cellular roles of Anthrax toxin—IL1B—systemic scleroderma	0.000452	0.00887	CbGpPWpGaD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—IRF5—systemic scleroderma	0.000449	0.0088	CbGpPWpGaD
Chloroquine—GSTA2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	0.000448	0.0088	CbGpPWpGaD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	0.000447	0.00877	CbGpPWpGaD
Chloroquine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000447	0.00321	CcSEcCtD
Chloroquine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000447	0.00321	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—RHOB—systemic scleroderma	0.000446	0.00874	CbGpPWpGaD
Chloroquine—Insomnia—Captopril—systemic scleroderma	0.000445	0.0032	CcSEcCtD
Chloroquine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000444	0.00319	CcSEcCtD
Chloroquine—Abdominal pain—Mometasone—systemic scleroderma	0.000443	0.00318	CcSEcCtD
Chloroquine—TNF—Matrix Metalloproteinases—MMP2—systemic scleroderma	0.000443	0.00868	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.00044	0.00863	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—TNFAIP3—systemic scleroderma	0.000436	0.00856	CbGpPWpGaD
Chloroquine—Agitation—Mycophenolic acid—systemic scleroderma	0.000436	0.00313	CcSEcCtD
Chloroquine—Alopecia—Lisinopril—systemic scleroderma	0.000434	0.00312	CcSEcCtD
Chloroquine—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00043	0.00309	CcSEcCtD
Chloroquine—Decreased appetite—Captopril—systemic scleroderma	0.000428	0.00308	CcSEcCtD
Chloroquine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000428	0.00307	CcSEcCtD
Chloroquine—Anxiety—Leflunomide—systemic scleroderma	0.000422	0.00303	CcSEcCtD
Chloroquine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000421	0.00302	CcSEcCtD
Chloroquine—TNF—amb2 Integrin signaling—MMP2—systemic scleroderma	0.000421	0.00825	CbGpPWpGaD
Chloroquine—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.000414	0.00298	CcSEcCtD
Chloroquine—Vomiting—Pentoxifylline—systemic scleroderma	0.000413	0.00297	CcSEcCtD
Chloroquine—Psychotic disorder—Prednisone—systemic scleroderma	0.000411	0.00296	CcSEcCtD
Chloroquine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000411	0.00295	CcSEcCtD
Chloroquine—Rash—Pentoxifylline—systemic scleroderma	0.000409	0.00294	CcSEcCtD
Chloroquine—Headache—Pentoxifylline—systemic scleroderma	0.000407	0.00292	CcSEcCtD
Chloroquine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000406	0.00292	CcSEcCtD
Chloroquine—Feeling abnormal—Captopril—systemic scleroderma	0.000406	0.00292	CcSEcCtD
Chloroquine—Vision blurred—Lisinopril—systemic scleroderma	0.000402	0.00289	CcSEcCtD
Chloroquine—Anxiety—Mycophenolic acid—systemic scleroderma	0.000402	0.00289	CcSEcCtD
Chloroquine—Asthenia—Mometasone—systemic scleroderma	0.000402	0.00289	CcSEcCtD
Chloroquine—Hypotension—Azathioprine—systemic scleroderma	0.000401	0.00289	CcSEcCtD
Chloroquine—Photosensitivity—Methotrexate—systemic scleroderma	0.000401	0.00288	CcSEcCtD
Chloroquine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000401	0.00288	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—CTLA4—systemic scleroderma	0.000399	0.00782	CbGpPWpGaD
Chloroquine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000397	0.00286	CcSEcCtD
Chloroquine—Pruritus—Mometasone—systemic scleroderma	0.000396	0.00285	CcSEcCtD
Chloroquine—TNF—IL27-mediated signaling events—IL1B—systemic scleroderma	0.000396	0.00776	CbGpPWpGaD
Chloroquine—TNF—IL23-mediated signaling events—CCL2—systemic scleroderma	0.000394	0.00772	CbGpPWpGaD
Chloroquine—Angioedema—Lisinopril—systemic scleroderma	0.00039	0.00281	CcSEcCtD
Chloroquine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00039	0.00281	CcSEcCtD
Chloroquine—Abdominal pain—Captopril—systemic scleroderma	0.000389	0.0028	CcSEcCtD
Chloroquine—Anorexia—Leflunomide—systemic scleroderma	0.000387	0.00278	CcSEcCtD
Chloroquine—Nausea—Pentoxifylline—systemic scleroderma	0.000386	0.00277	CcSEcCtD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL1B—systemic scleroderma	0.000384	0.00753	CbGpPWpGaD
Chloroquine—CYP1A1—Melatonin metabolism and effects—EDN1—systemic scleroderma	0.000384	0.00753	CbGpPWpGaD
Chloroquine—Diarrhoea—Mometasone—systemic scleroderma	0.000383	0.00276	CcSEcCtD
Chloroquine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00038	0.00273	CcSEcCtD
Chloroquine—Hypotension—Leflunomide—systemic scleroderma	0.000379	0.00272	CcSEcCtD
Chloroquine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000379	0.00272	CcSEcCtD
Chloroquine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000373	0.00268	CcSEcCtD
Chloroquine—Visual disturbance—Methotrexate—systemic scleroderma	0.000371	0.00267	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000371	0.00267	CcSEcCtD
Chloroquine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000369	0.00265	CcSEcCtD
Chloroquine—Insomnia—Leflunomide—systemic scleroderma	0.000367	0.00264	CcSEcCtD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	0.000364	0.00714	CbGpPWpGaD
Chloroquine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000364	0.00261	CcSEcCtD
Chloroquine—Anxiety—Lisinopril—systemic scleroderma	0.000362	0.0026	CcSEcCtD
Chloroquine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000362	0.0026	CcSEcCtD
Chloroquine—Vomiting—Mometasone—systemic scleroderma	0.000356	0.00256	CcSEcCtD
Chloroquine—TNF—TWEAK Signaling Pathway—CCL2—systemic scleroderma	0.000356	0.00697	CbGpPWpGaD
Chloroquine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000354	0.00254	CcSEcCtD
Chloroquine—Rash—Mometasone—systemic scleroderma	0.000353	0.00254	CcSEcCtD
Chloroquine—Asthenia—Captopril—systemic scleroderma	0.000353	0.00254	CcSEcCtD
Chloroquine—Decreased appetite—Leflunomide—systemic scleroderma	0.000353	0.00254	CcSEcCtD
Chloroquine—Confusional state—Lisinopril—systemic scleroderma	0.000351	0.00253	CcSEcCtD
Chloroquine—Headache—Mometasone—systemic scleroderma	0.000351	0.00252	CcSEcCtD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—IRF5—systemic scleroderma	0.00035	0.00687	CbGpPWpGaD
Chloroquine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00035	0.00252	CcSEcCtD
Chloroquine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00035	0.00252	CcSEcCtD
Chloroquine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000349	0.00251	CcSEcCtD
Chloroquine—Pruritus—Captopril—systemic scleroderma	0.000348	0.0025	CcSEcCtD
Chloroquine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000344	0.00247	CcSEcCtD
Chloroquine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00246	CcSEcCtD
Chloroquine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000341	0.00245	CcSEcCtD
Chloroquine—Neutropenia—Prednisone—systemic scleroderma	0.00034	0.00245	CcSEcCtD
Chloroquine—Abdominal pain—Azathioprine—systemic scleroderma	0.00034	0.00244	CcSEcCtD
Chloroquine—Diarrhoea—Captopril—systemic scleroderma	0.000337	0.00242	CcSEcCtD
Chloroquine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000336	0.00242	CcSEcCtD
Chloroquine—TNF—Monoamine Transport—IL1B—systemic scleroderma	0.000335	0.00657	CbGpPWpGaD
Chloroquine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000334	0.0024	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000334	0.0024	CcSEcCtD
Chloroquine—Nausea—Mometasone—systemic scleroderma	0.000333	0.00239	CcSEcCtD
Chloroquine—TNF—Matrix Metalloproteinases—MMP9—systemic scleroderma	0.000333	0.00653	CbGpPWpGaD
Chloroquine—Anorexia—Lisinopril—systemic scleroderma	0.000332	0.00239	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—HLA-DQB1—systemic scleroderma	0.000328	0.00644	CbGpPWpGaD
Chloroquine—Hypotension—Lisinopril—systemic scleroderma	0.000326	0.00234	CcSEcCtD
Chloroquine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000324	0.00233	CcSEcCtD
Chloroquine—Urticaria—Leflunomide—systemic scleroderma	0.000322	0.00232	CcSEcCtD
Chloroquine—Abdominal pain—Leflunomide—systemic scleroderma	0.000321	0.00231	CcSEcCtD
Chloroquine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000319	0.00229	CcSEcCtD
Chloroquine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000317	0.00228	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000317	0.00228	CcSEcCtD
Chloroquine—TNF—amb2 Integrin signaling—MMP9—systemic scleroderma	0.000316	0.0062	CbGpPWpGaD
Chloroquine—Insomnia—Lisinopril—systemic scleroderma	0.000315	0.00227	CcSEcCtD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—TNFAIP3—systemic scleroderma	0.000314	0.00615	CbGpPWpGaD
Chloroquine—Vomiting—Captopril—systemic scleroderma	0.000313	0.00225	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—IL1A—systemic scleroderma	0.000312	0.00612	CbGpPWpGaD
Chloroquine—Rash—Captopril—systemic scleroderma	0.00031	0.00223	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—CD40LG—systemic scleroderma	0.00031	0.00608	CbGpPWpGaD
Chloroquine—Headache—Captopril—systemic scleroderma	0.000308	0.00222	CcSEcCtD
Chloroquine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000308	0.00221	CcSEcCtD
Chloroquine—TNF—IL27-mediated signaling events—TGFB1—systemic scleroderma	0.000308	0.00603	CbGpPWpGaD
Chloroquine—TNF—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic scleroderma	0.000308	0.00603	CbGpPWpGaD
Chloroquine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000306	0.0022	CcSEcCtD
Chloroquine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000305	0.0022	CcSEcCtD
Chloroquine—TNF—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.000304	0.00597	CbGpPWpGaD
Chloroquine—Decreased appetite—Lisinopril—systemic scleroderma	0.000303	0.00218	CcSEcCtD
Chloroquine—Eosinophilia—Methotrexate—systemic scleroderma	0.000301	0.00217	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000301	0.00216	CcSEcCtD
Chloroquine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000299	0.00215	CcSEcCtD
Chloroquine—TNF—MicroRNAs in cardiomyocyte hypertrophy—EDN1—systemic scleroderma	0.000299	0.00586	CbGpPWpGaD
Chloroquine—TNF—IL23-mediated signaling events—IL1B—systemic scleroderma	0.000298	0.00585	CbGpPWpGaD
Chloroquine—TNF—Cytokines and Inflammatory Response—TGFB1—systemic scleroderma	0.000298	0.00585	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—ITGAM—systemic scleroderma	0.000295	0.00578	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—CD247—systemic scleroderma	0.000295	0.00578	CbGpPWpGaD
Chloroquine—TNF—Angiopoietin receptor Tie2-mediated signaling—MMP2—systemic scleroderma	0.000294	0.00577	CbGpPWpGaD
Chloroquine—Diarrhoea—Azathioprine—systemic scleroderma	0.000294	0.00211	CcSEcCtD
Chloroquine—Nausea—Captopril—systemic scleroderma	0.000292	0.0021	CcSEcCtD
Chloroquine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000291	0.00209	CcSEcCtD
Chloroquine—Asthenia—Leflunomide—systemic scleroderma	0.000291	0.00209	CcSEcCtD
Chloroquine—Hallucination—Prednisone—systemic scleroderma	0.00029	0.00208	CcSEcCtD
Chloroquine—CYP2D6—Melatonin metabolism and effects—EDN1—systemic scleroderma	0.000289	0.00567	CbGpPWpGaD
Chloroquine—Pancytopenia—Methotrexate—systemic scleroderma	0.000289	0.00208	CcSEcCtD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.000288	0.00564	CbGpPWpGaD
Chloroquine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000287	0.00206	CcSEcCtD
Chloroquine—Pruritus—Leflunomide—systemic scleroderma	0.000287	0.00206	CcSEcCtD
Chloroquine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00205	CcSEcCtD
Chloroquine—Neutropenia—Methotrexate—systemic scleroderma	0.000284	0.00205	CcSEcCtD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	0.000284	0.00558	CbGpPWpGaD
Chloroquine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000278	0.002	CcSEcCtD
Chloroquine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000278	0.002	CcSEcCtD
Chloroquine—Diarrhoea—Leflunomide—systemic scleroderma	0.000278	0.002	CcSEcCtD
Chloroquine—Urticaria—Lisinopril—systemic scleroderma	0.000277	0.00199	CcSEcCtD
Chloroquine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000276	0.00199	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—TNFAIP3—systemic scleroderma	0.000276	0.00541	CbGpPWpGaD
Chloroquine—TNF—Angiopoietin receptor Tie2-mediated signaling—NOS3—systemic scleroderma	0.000276	0.00541	CbGpPWpGaD
Chloroquine—Abdominal pain—Lisinopril—systemic scleroderma	0.000276	0.00198	CcSEcCtD
Chloroquine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000274	0.00197	CcSEcCtD
Chloroquine—Vomiting—Azathioprine—systemic scleroderma	0.000273	0.00196	CcSEcCtD
Chloroquine—Rash—Azathioprine—systemic scleroderma	0.000271	0.00195	CcSEcCtD
Chloroquine—Headache—Azathioprine—systemic scleroderma	0.000269	0.00193	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000269	0.00193	CcSEcCtD
Chloroquine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000265	0.00191	CcSEcCtD
Chloroquine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000265	0.0019	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000264	0.0019	CcSEcCtD
Chloroquine—Vomiting—Leflunomide—systemic scleroderma	0.000258	0.00185	CcSEcCtD
Chloroquine—Alopecia—Prednisone—systemic scleroderma	0.000257	0.00185	CcSEcCtD
Chloroquine—Rash—Leflunomide—systemic scleroderma	0.000256	0.00184	CcSEcCtD
Chloroquine—Nausea—Azathioprine—systemic scleroderma	0.000255	0.00183	CcSEcCtD
Chloroquine—TNF—TWEAK Signaling Pathway—MMP9—systemic scleroderma	0.000254	0.00499	CbGpPWpGaD
Chloroquine—Headache—Leflunomide—systemic scleroderma	0.000254	0.00183	CcSEcCtD
Chloroquine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000253	0.00182	CcSEcCtD
Chloroquine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000252	0.00181	CcSEcCtD
Chloroquine—TNF—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	0.000251	0.00492	CbGpPWpGaD
Chloroquine—Asthenia—Lisinopril—systemic scleroderma	0.00025	0.0018	CcSEcCtD
Chloroquine—TNF—Folate Metabolism—CCL2—systemic scleroderma	0.000248	0.00486	CbGpPWpGaD
Chloroquine—Pruritus—Lisinopril—systemic scleroderma	0.000247	0.00177	CcSEcCtD
Chloroquine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000246	0.00177	CcSEcCtD
Chloroquine—Rash—Mycophenolic acid—systemic scleroderma	0.000244	0.00175	CcSEcCtD
Chloroquine—Hepatitis—Methotrexate—systemic scleroderma	0.000244	0.00175	CcSEcCtD
Chloroquine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000243	0.00174	CcSEcCtD
Chloroquine—Headache—Mycophenolic acid—systemic scleroderma	0.000242	0.00174	CcSEcCtD
Chloroquine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000241	0.00174	CcSEcCtD
Chloroquine—Nausea—Leflunomide—systemic scleroderma	0.000241	0.00173	CcSEcCtD
Chloroquine—Vision blurred—Prednisone—systemic scleroderma	0.000239	0.00172	CcSEcCtD
Chloroquine—Diarrhoea—Lisinopril—systemic scleroderma	0.000238	0.00171	CcSEcCtD
Chloroquine—Visual impairment—Methotrexate—systemic scleroderma	0.000235	0.00169	CcSEcCtD
Chloroquine—Agitation—Prednisone—systemic scleroderma	0.000233	0.00168	CcSEcCtD
Chloroquine—Angioedema—Prednisone—systemic scleroderma	0.000232	0.00167	CcSEcCtD
Chloroquine—TNF—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.000231	0.00453	CbGpPWpGaD
Chloroquine—Erythema multiforme—Methotrexate—systemic scleroderma	0.00023	0.00166	CcSEcCtD
Chloroquine—Nausea—Mycophenolic acid—systemic scleroderma	0.00023	0.00165	CcSEcCtD
Chloroquine—Tinnitus—Methotrexate—systemic scleroderma	0.000227	0.00163	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—IL1A—systemic scleroderma	0.000226	0.00444	CbGpPWpGaD
Chloroquine—Vomiting—Lisinopril—systemic scleroderma	0.000222	0.00159	CcSEcCtD
Chloroquine—Rash—Lisinopril—systemic scleroderma	0.00022	0.00158	CcSEcCtD
Chloroquine—Convulsion—Prednisone—systemic scleroderma	0.00022	0.00158	CcSEcCtD
Chloroquine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000219	0.00158	CcSEcCtD
Chloroquine—Headache—Lisinopril—systemic scleroderma	0.000218	0.00157	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IL13—systemic scleroderma	0.000217	0.00426	CbGpPWpGaD
Chloroquine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000216	0.00155	CcSEcCtD
Chloroquine—Anxiety—Prednisone—systemic scleroderma	0.000215	0.00155	CcSEcCtD
Chloroquine—Alopecia—Methotrexate—systemic scleroderma	0.000215	0.00155	CcSEcCtD
Chloroquine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000209	0.0015	CcSEcCtD
Chloroquine—Nausea—Lisinopril—systemic scleroderma	0.000207	0.00149	CcSEcCtD
Chloroquine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000207	0.00149	CcSEcCtD
Chloroquine—Vision blurred—Methotrexate—systemic scleroderma	0.0002	0.00144	CcSEcCtD
Chloroquine—Anorexia—Prednisone—systemic scleroderma	0.000197	0.00142	CcSEcCtD
Chloroquine—TNF—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000197	0.00386	CbGpPWpGaD
Chloroquine—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	0.000195	0.00382	CbGpPWpGaD
Chloroquine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000194	0.0014	CcSEcCtD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000193	0.00378	CbGpPWpGaD
Chloroquine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000193	0.00138	CcSEcCtD
Chloroquine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000191	0.00138	CcSEcCtD
Chloroquine—TNF—TNF alpha Signaling Pathway—CCL2—systemic scleroderma	0.00019	0.00372	CbGpPWpGaD
Chloroquine—TNF—Folate Metabolism—IL1B—systemic scleroderma	0.000188	0.00368	CbGpPWpGaD
Chloroquine—Insomnia—Prednisone—systemic scleroderma	0.000187	0.00135	CcSEcCtD
Chloroquine—CYP1A1—PPARA activates gene expression—CTGF—systemic scleroderma	0.000185	0.00363	CbGpPWpGaD
Chloroquine—Convulsion—Methotrexate—systemic scleroderma	0.000184	0.00132	CcSEcCtD
Chloroquine—TLR9—Immune System—CSK—systemic scleroderma	0.000182	0.00358	CbGpPWpGaD
Chloroquine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000181	0.0013	CcSEcCtD
Chloroquine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—systemic scleroderma	0.000181	0.00355	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000181	0.00355	CbGpPWpGaD
Chloroquine—Decreased appetite—Prednisone—systemic scleroderma	0.00018	0.00129	CcSEcCtD
Chloroquine—TLR9—Immune System—IRF5—systemic scleroderma	0.00018	0.00352	CbGpPWpGaD
Chloroquine—GSTA2—NRF2 pathway—TGFB1—systemic scleroderma	0.000178	0.00349	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—CTLA4—systemic scleroderma	0.000175	0.00343	CbGpPWpGaD
Chloroquine—Confusional state—Methotrexate—systemic scleroderma	0.000174	0.00125	CcSEcCtD
Chloroquine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000173	0.00124	CcSEcCtD
Chloroquine—TLR9—Immune System—IRF8—systemic scleroderma	0.000172	0.00336	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD247—systemic scleroderma	0.000172	0.00336	CbGpPWpGaD
Chloroquine—TLR9—Immune System—ITGAM—systemic scleroderma	0.000172	0.00336	CbGpPWpGaD
Chloroquine—TNF—TGF-beta Receptor Signaling—TGFB1—systemic scleroderma	0.000171	0.00336	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—IL1A—systemic scleroderma	0.000171	0.00335	CbGpPWpGaD
Chloroquine—Feeling abnormal—Prednisone—systemic scleroderma	0.000171	0.00123	CcSEcCtD
Chloroquine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000169	0.00122	CcSEcCtD
Chloroquine—TNF—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	0.000169	0.00331	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—SMAD7—systemic scleroderma	0.000167	0.00328	CbGpPWpGaD
Chloroquine—Anorexia—Methotrexate—systemic scleroderma	0.000165	0.00119	CcSEcCtD
Chloroquine—Urticaria—Prednisone—systemic scleroderma	0.000164	0.00118	CcSEcCtD
Chloroquine—Abdominal pain—Prednisone—systemic scleroderma	0.000164	0.00118	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—IL1B—systemic scleroderma	0.000163	0.00319	CbGpPWpGaD
Chloroquine—TNF—Alzheimers Disease—IL1B—systemic scleroderma	0.000163	0.00319	CbGpPWpGaD
Chloroquine—Hypotension—Methotrexate—systemic scleroderma	0.000162	0.00116	CcSEcCtD
Chloroquine—TLR9—Immune System—TNFAIP3—systemic scleroderma	0.000161	0.00315	CbGpPWpGaD
Chloroquine—ABCB1—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	0.000159	0.00312	CbGpPWpGaD
Chloroquine—TLR9—Immune System—BLK—systemic scleroderma	0.000159	0.00311	CbGpPWpGaD
Chloroquine—Insomnia—Methotrexate—systemic scleroderma	0.000156	0.00112	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—CCL2—systemic scleroderma	0.000156	0.00305	CbGpPWpGaD
Chloroquine—Decreased appetite—Methotrexate—systemic scleroderma	0.00015	0.00108	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000149	0.00107	CcSEcCtD
Chloroquine—TNF—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000149	0.00293	CbGpPWpGaD
Chloroquine—Asthenia—Prednisone—systemic scleroderma	0.000149	0.00107	CcSEcCtD
Chloroquine—Pruritus—Prednisone—systemic scleroderma	0.000146	0.00105	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—HLA-DQB1—systemic scleroderma	0.000144	0.00282	CbGpPWpGaD
Chloroquine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000143	0.00102	CcSEcCtD
Chloroquine—TNF—Developmental Biology—RHOB—systemic scleroderma	0.000142	0.00278	CbGpPWpGaD
Chloroquine—Diarrhoea—Prednisone—systemic scleroderma	0.000142	0.00102	CcSEcCtD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	0.000138	0.0027	CbGpPWpGaD
Chloroquine—Urticaria—Methotrexate—systemic scleroderma	0.000137	0.000988	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IL1A—systemic scleroderma	0.000137	0.00268	CbGpPWpGaD
Chloroquine—Abdominal pain—Methotrexate—systemic scleroderma	0.000137	0.000983	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—CD40LG—systemic scleroderma	0.000136	0.00267	CbGpPWpGaD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	0.000133	0.0026	CbGpPWpGaD
Chloroquine—Vomiting—Prednisone—systemic scleroderma	0.000132	0.000946	CcSEcCtD
Chloroquine—Rash—Prednisone—systemic scleroderma	0.000131	0.000938	CcSEcCtD
Chloroquine—TLR9—Immune System—CTLA4—systemic scleroderma	0.00013	0.00255	CbGpPWpGaD
Chloroquine—Headache—Prednisone—systemic scleroderma	0.00013	0.000932	CcSEcCtD
Chloroquine—TLR9—Signaling Pathways—RHOB—systemic scleroderma	0.00013	0.00254	CbGpPWpGaD
Chloroquine—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic scleroderma	0.000129	0.00253	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—TGFB1—systemic scleroderma	0.000126	0.00248	CbGpPWpGaD
Chloroquine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	0.000125	0.00245	CbGpPWpGaD
Chloroquine—Asthenia—Methotrexate—systemic scleroderma	0.000124	0.000892	CcSEcCtD
Chloroquine—Nausea—Prednisone—systemic scleroderma	0.000123	0.000884	CcSEcCtD
Chloroquine—GSTA2—Metabolism—HSPG2—systemic scleroderma	0.000122	0.0024	CbGpPWpGaD
Chloroquine—Pruritus—Methotrexate—systemic scleroderma	0.000122	0.00088	CcSEcCtD
Chloroquine—TLR9—Signaling Pathways—HSPG2—systemic scleroderma	0.000122	0.0024	CbGpPWpGaD
Chloroquine—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	0.00012	0.00236	CbGpPWpGaD
Chloroquine—Diarrhoea—Methotrexate—systemic scleroderma	0.000118	0.000851	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—IL1B—systemic scleroderma	0.000118	0.00231	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CSK—systemic scleroderma	0.000118	0.00231	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—MMP9—systemic scleroderma	0.000111	0.00218	CbGpPWpGaD
Chloroquine—Vomiting—Methotrexate—systemic scleroderma	0.00011	0.000791	CcSEcCtD
Chloroquine—Rash—Methotrexate—systemic scleroderma	0.000109	0.000784	CcSEcCtD
Chloroquine—Headache—Methotrexate—systemic scleroderma	0.000108	0.000779	CcSEcCtD
Chloroquine—TLR9—Immune System—HLA-DQB1—systemic scleroderma	0.000107	0.0021	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	0.000107	0.0021	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	0.000104	0.00203	CbGpPWpGaD
Chloroquine—Nausea—Methotrexate—systemic scleroderma	0.000103	0.000739	CcSEcCtD
Chloroquine—TLR9—Immune System—IL1A—systemic scleroderma	0.000102	0.00199	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD40LG—systemic scleroderma	0.000101	0.00198	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	9.44e-05	0.00185	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—CTGF—systemic scleroderma	9.28e-05	0.00182	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—TGFB1—systemic scleroderma	9.17e-05	0.0018	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—IL1B—systemic scleroderma	8.9e-05	0.00174	CbGpPWpGaD
Chloroquine—TNF—Adipogenesis—TGFB1—systemic scleroderma	8.49e-05	0.00166	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	7.13e-05	0.0014	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—TGFB1—systemic scleroderma	6.91e-05	0.00136	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—EDN1—systemic scleroderma	6.61e-05	0.0013	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	6.56e-05	0.00129	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	6.24e-05	0.00122	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	6.01e-05	0.00118	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	5.54e-05	0.00109	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IL1B—systemic scleroderma	5.3e-05	0.00104	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.97e-05	0.000974	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—MMP2—systemic scleroderma	4.71e-05	0.000924	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.56e-05	0.000893	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCL2—systemic scleroderma	4.52e-05	0.000887	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—NOS3—systemic scleroderma	4.04e-05	0.000792	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—NOS3—systemic scleroderma	4.03e-05	0.00079	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—MMP9—systemic scleroderma	3.54e-05	0.000694	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—MMP9—systemic scleroderma	3.23e-05	0.000634	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—HSPG2—systemic scleroderma	3.09e-05	0.000606	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—HSPG2—systemic scleroderma	2.92e-05	0.000573	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—TGFB1—systemic scleroderma	2.92e-05	0.000572	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	2.74e-05	0.000536	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—HSPG2—systemic scleroderma	2.68e-05	0.000525	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—TGFB1—systemic scleroderma	2.66e-05	0.000523	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—CTGF—systemic scleroderma	2.34e-05	0.000459	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—HSPG2—systemic scleroderma	2.33e-05	0.000457	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—CTGF—systemic scleroderma	2.21e-05	0.000434	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—HSPG2—systemic scleroderma	2.2e-05	0.000431	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—CTGF—systemic scleroderma	2.03e-05	0.000398	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—CTGF—systemic scleroderma	1.77e-05	0.000347	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—CTGF—systemic scleroderma	1.67e-05	0.000327	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—HSPG2—systemic scleroderma	1.44e-05	0.000282	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—CTGF—systemic scleroderma	1.09e-05	0.000214	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—NOS3—systemic scleroderma	1.02e-05	0.0002	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—NOS3—systemic scleroderma	9.63e-06	0.000189	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—NOS3—systemic scleroderma	8.83e-06	0.000173	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—NOS3—systemic scleroderma	7.69e-06	0.000151	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—NOS3—systemic scleroderma	7.25e-06	0.000142	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—NOS3—systemic scleroderma	4.74e-06	9.29e-05	CbGpPWpGaD
